Topic

MSCA-IF-2014-EF

MSCA-IF-2014-EF

Programme: H2020

1217 projects · €215,840,546 total EU contribution (project-level) · 380 participating organizations · 29 countries with participants

Total EU funding

Sum of EC max contribution fields for distinct projects in this topic.

€215,840,546

Countries active

Participant organizations by country (headquarters in CORDIS).

  • UK (78)
  • Spain (56)
  • Germany (46)
  • France (40)
  • Italy (26)
  • Netherlands (23)
  • AT (13)
  • BE (12)
  • SE (11)
  • IE (9)
  • DK (8)
  • EL (7)
  • TR (7)
  • FI (6)
  • HU (5)
  • IL (5)
  • PT (5)
  • NO (4)
  • PL (4)
  • CZ (3)
  • EE (2)
  • HR (2)
  • LU (2)
  • BG (1)
  • CH (1)
  • CY (1)
  • IS (1)
  • LT (1)
  • SI (1)

Open calls

From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.

No open or forthcoming calls linked to this topic in the database yet.

Top organizations

By number of distinct projects in this topic.

Projects

Page 8 of 122

ProjectEU contribution

Optical point of care system for heart failure mass screening

COSMOS · 661484

€185,076
Details

Solution processed low-dimensional oxide semiconducting structures and devices

SUPERSOL · 661127

€195,455
Details

The cardiovascular consequences of endurance exercise

CARDI-ACHE · 655502

€183,455
Details

The role of macroPARAsite COinfection in Rodent-borne microparasite Transmission

PARACORT · 661690

€112,673
Details

In search for endothelial mechanisms of TPO-induced neuroprotection

TONEURENDO · 660946

€146,462
Details

Art and Brain: An integrated approach to causative analysis of neural function in perception of art using Transcranial Magnetic Stimulation

Art and Brain · 655379

€178,157
Details

Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages

NANOTAM · 658592

€168,277
Details

Nanoarrays: Self-assembled Hotspots for Enhanced Analyte Detection

N-SHEAD · 658554

€183,455
Details

A versatile platform for the design of targeting drug delivery vesicles

VesSenDrugDeliv · 659130

€195,455
Details

Development of Palladium-Labile Prodrugs for Bioorthogonally-Activated Chemotherapy

ChemoBOOM · 658833

€183,455
Details